logo
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative

TAMPA, FLORIDA / ACCESS Newswire / May 8, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based digital asset, as both a treasury reserve and a real-time payments infrastructure-which management believes, upon successful commercialization, would make Wellgistics among the first publicly traded healthcare companies to deploy XRP in this manner.
This XRP payment initiative is supported by Wellgistics Health's $50 million Equity Line of Credit (ELOC), the proceeds of which may be utilized to further develop and unlock programmable liquidity and on-demand financial infrastructure designed to eliminate banking delays, reduce cost, and increase transparency across its national healthcare network.
'At Wellgistics Health, we challenge the idea that healthcare has to be tethered to legacy systems, bloated intermediaries, and slow-moving money,' said Brian Norton, CEO of Wellgistics Health. 'We are developing a platform that connects manufacturers directly to pharmacies and patients-bypassing the red tape and placing control back in the hands of those who deliver care. Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that's long been starved of all three. I believe that the future winners in healthcare won't be the companies with the biggest buildings…they'll be those with the fastest rails, cleanest data, and most efficient platforms. We're betting on infrastructure…not inertia.'
Why XRP? Why Now?
We believe that there are certain advantages to integrating XRP and its related infrastructure into its healthcare ecosystem. These include, among others:
These benefits will support faster vendor payments, performance-based rebates, and embedded liquidity tools for pharmacies and manufacturers in the Wellgistics ecosystem.
Use Cases Across the Ecosystem
'We're working to unlock capital velocity with surgical precision,' said Mark DiSiena, CFO of Wellgistics Health. 'We believe that our XRP-powered infrastructure will allow us to run leaner, faster, and with more control than any of our peers in pharma infrastructure.'
The Market Is Moving-And Wellgistics Intends to Lead
XRP is gaining momentum across global institutions, as demonstrated by the following:
'Others are waiting for change. We're building it,' Norton added. 'I strongly believe that our XRP initiative positions Wellgistics Health years ahead of the curve-and squarely at the center of where healthcare and fintech converge.'
About Wellgistics Health
Wellgistics Health, Inc. (NASDAQ:WGRX) is a publicly traded healthcare infrastructure company transforming how medications move, get priced, and reach patients. The company operates across pharmaceutical distribution, prescription technology, and clinical fulfillment-connecting over 150 direct manufacturer contracts to a growing network of more than 6,000 independent pharmacies nationwide.
Wellgistics Health delivers real-time prescription hub services, compliance-driven logistics, and patient-first fulfillment models, while equipping pharmacies with embedded financial, clinical, and digital tools. Its integrated platform supports a wide range of therapeutic categories-from specialty-lite to maintenance meds-by eliminating friction, accelerating reimbursements, and creating direct, transparent pathways between manufacturers, providers, pharmacies, and patients.
For more information, visit: www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as 'may, 'will, 'intend,' 'should,' 'believe,' 'expect,' 'anticipate,' 'project,' 'estimate' or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
Media Contact: [email protected]
Investor Relations: [email protected]
References
SOURCE: Wellgistics Health, Inc.
press release

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

Business Wire

time16 minutes ago

  • Business Wire

Securities Fraud Investigation Into Neogen Corporation (NEOG) Continues – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz continues its investigation of Neogen Corporation ('Neogen' or the 'Company') (NASDAQ: NEOG) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NEOGEN CORPORATION (NEOG), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On June 4, 2025, Neogen disclosed that, while its fourth quarter fiscal 2025 financial results would be 'materially approximate [to] where [the Company] had put [its] guide,' it 'would expect EBITDA margin to probably be around the high-teens' compared to the previous quarter's 22%. The Company explained that EBITDA margins would likely 'be in the low-20s, if not for the elevated inventory write-offs.' On this news, Neogen's stock price fell $1.04, or 17.3%, to close at $4.96 per share on June 4, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Neogen securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: The Law Offices of Frank R. Cruz, 2121 Avenue of the Stars, Suite 800, Century City, California 90067 Call us at: 310-914-5007 Email us at: info@ Visit our website at: Follow us for updates on Twitter at If you inquire by email, please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Informa TechTarget and Salesloft Announce Strategic Partnership to Help Customers Grow Revenue Through Precise, Data-Driven Prospecting
Informa TechTarget and Salesloft Announce Strategic Partnership to Help Customers Grow Revenue Through Precise, Data-Driven Prospecting

Yahoo

time19 minutes ago

  • Yahoo

Informa TechTarget and Salesloft Announce Strategic Partnership to Help Customers Grow Revenue Through Precise, Data-Driven Prospecting

Together, the companies help sellers engage with active buying groups showing demonstrated interest in and genuine need for their solutions. NEWTON, Mass. & ATLANTA, June 23, 2025--(BUSINESS WIRE)--TechTarget, Inc. ("Informa TechTarget") (Nasdaq: TTGT), global growth accelerator and leading provider of intent data and insights to the B2B technology sector, and Salesloft, a leading Revenue Orchestration Platform that helps B2B organizations drive durable revenue growth, today announced a partnership and integration designed to help mutual customers build and accelerate pipeline by efficiently identifying and effectively engaging prospects in an active buying journey. "While 85% of BDRs are laser-focused on outbound prospecting, many of them waste precious cycles pursuing cold contacts who aren't ready to buy. We help reps hit their pipeline targets by identifying buyers who are actively researching relevant solutions through their membership to our trusted editorial communities," said Jillian Coffin, Senior Vice President of Customer Enablement and Strategy, Informa TechTarget. "By automatically delivering these active, permissioned contacts into topically aligned Salesloft cadences, we help sellers engage the right people with the right message at the right time so they can convert more interest into opportunity." The new integration empowers sales teams to: Streamline workflows between Informa TechTarget and Salesloft to maximize sales efficiency Easily add Active Prospects from Informa TechTarget's Priority Engine intent data platform directly into relevant Salesloft cadences in seconds Automatically push Active Prospects to topically aligned Salesloft cadences each week "The combination of Informa TechTarget's active, permissioned contacts with Salesloft's engagement capabilities gives sales teams a meaningful advantage," said Lesley Renna, SVP of Alliances and Ecosystem at Salesloft. "This integration helps our joint customers drive higher productivity and conversion rates by automatically adding prospects in an active buying cycle to Salesloft Cadences tailored to the topics that matter most to them." Key benefits of this strategic partnership include: Precision targeting: Customers can leverage Informa TechTarget's person-level intent data to confidently focus sellers on in-market buyers and buying groups in their territory or ABM targets. Accelerated engagement: Informa TechTarget constantly monitors for new individuals beginning their research journey and automatically delivers these permissioned buyers to Salesloft, drastically reducing the time between intent signals and sales outreach. Higher conversion: With Informa TechTarget, sellers get visibility into the needs, pain points, and current topics of interest for each individual buyer so they can better personalize across every touchpoint, which helps them book more meetings and have meaningful conversations that convert. "The Add to SEP feature integration between Priority Engine and Salesloft is impressively intuitive. I love how new additions appear right at the top in Salesloft," said Theresa Woodiel, Director, ABM & Integrated Marketing at Deep Instinct. "The seamless workflow means our reps can instantly see and engage with their newest priority contacts. It's exactly the kind of straightforward, efficient solution our team needs." The Informa TechTarget-Salesloft integration is available now to current Priority Engine Sales subscribers at no additional cost. Customers must have both a Priority Engine Sales subscription and a Salesloft license to utilize the integration. To learn more, click here. About Informa TechTarget TechTarget, Inc. (Nasdaq: TTGT), which also refers to itself as Informa TechTarget, informs, influences and connects the world's technology buyers and sellers, helping accelerate growth from R&D to ROI. With a vast reach of over 220 highly targeted technology-specific websites and over 50 million permissioned first-party audience members, Informa TechTarget has a unique understanding of and insight into the technology market. Underpinned by those audiences and their data, we offer expert-led, data-driven, and digitally enabled services that have the potential to deliver significant impact and measurable outcomes to our clients: Trusted information that shapes the industry and informs investment Intelligence and advice that guides and influences strategy Advertising that grows reputation and establishes thought leadership Custom content that engages and prompts action Intent and demand generation that more precisely targets and converts Informa TechTarget is headquartered in Boston, MA and has offices in 19 global locations. For more information, visit and follow us on LinkedIn. About Salesloft Salesloft powers durable revenue growth for the world's most demanding companies. Salesloft's industry-leading Revenue Orchestration Platform uses purpose-built AI to help market-facing teams prioritize and take action on what matters most, from first touch to upsell and renewal. More than 5,000 customers including Google, 3M, IBM, Shopify, Square, and Cisco gain a performance force multiplier with Salesloft by shifting to a durable revenue engagement model, helping them solve the complexities of modern B2B sales and unlock revenue efficiency. © 2025 TechTarget, Inc d/b/a Informa TechTarget. All rights reserved. All trademarks are the property of their respective owners. View source version on Contacts Garrett MannVP of Corporate CommunicationsInforma Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Steve Jobs Once Cited Leonardo Da Vinci's Example To Explain Why All 'Major' Thinkers Had This Trait That Made Them Exceptional
Steve Jobs Once Cited Leonardo Da Vinci's Example To Explain Why All 'Major' Thinkers Had This Trait That Made Them Exceptional

Yahoo

time22 minutes ago

  • Yahoo

Steve Jobs Once Cited Leonardo Da Vinci's Example To Explain Why All 'Major' Thinkers Had This Trait That Made Them Exceptional

Steve Jobs once argued the greatest innovators are "both the thinker and doer in one person," invoking Leonardo da Vinci to prove that creativity and execution rarely succeed apart. What Happened: Addressing engineers in the early 1990s, the Apple (NASDAQ:APPL) co-founder said, "The doers are the major thinkers. ... Did Leonardo have a guy off to the side thinking five years out what he would paint? Of course not. Leonardo was the artist, but he also mixed all his own paints." Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — Jobs's point is that discovery flows from hands-on mastery. "It's very easy to take credit for thinking," he said. "Dig a little deeper and you find the people who really did it were also the people that worked through the hard intellectual problems as well."Veteran biographers note Jobs often cited Renaissance polymaths to justify Apple's marriage of hardware, software and It Matters: The thinker-doer thesis now frames a broader debate over when entrepreneurs hit their stride. Census Bureau data show founders aged 40-plus are likelier to build high-growth firms than their twenty-something peers, a pattern echoed by late-blooming icons such as Ray Kroc at McDonald's Corp. (NYSE:MCD) and Sam Walton at Walmart Inc. (NYSE:WMT). The gap reflects years spent 'doing,' honing skills and spotting problems first-hand before leaping to 'think' up solutions. Modern CEOs frequently echo Jobs. Tesla Inc.'s (NASDAQ:TSLA) Elon Musk reposted the quote last year with a one-word endorsement: "True." Venture capitalist Paul Graham tells founders to "learn by building" because abstract ideation rarely survives first contact with users. For Jobs, that convergence of art and engineering remained Apple's guiding doctrine until his 2011 death. "There is no difference in our industry," he said. "The people that have really made the contributions have been the thinkers and the doers." Read Next: Invest early in CancerVax's breakthrough tech aiming to disrupt a $231B market. Back a bold new approach to cancer treatment with high-growth potential. These five entrepreneurs are worth $223 billion – they all believe in one platform that offers a 7-9% target yield with monthly dividends Photo Courtesy: rnkadsgn on Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Steve Jobs Once Cited Leonardo Da Vinci's Example To Explain Why All 'Major' Thinkers Had This Trait That Made Them Exceptional originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store